Transcend Global and Corporate Boundaries During Drug Development

Transcend Global and Corporate Boundaries During Drug Development

Conference: DIA

We developed an innovative and alternative web-based strategy which combines a hypertext environment with human intelligence and creativity to lead a scientific audience through complex statistical…

Integrating Real-Time Data Assembly (RTDA) and Population Pharmacokinetics as Tactical Components of Cognitive Engineering

Integrating Real-Time Data Assembly (RTDA) and Population Pharmacokinetics as Tactical Components of Cognitive Engineering

Conference: DIA

The goal of drug development is to produce a safe and efficacious drug that will thrive in a competitive marketplace. Cognitive engineering couples technology and human intelligence to generate and use…

Ties in Proximity and Clustering Compounds

Ties in Proximity and Clustering Compounds

Publication: J Chem Inf Model
Software: MedChem Studio™

Hierarchical clustering algorithms such as Wards or complete-link are commonly used in compound selection and diversity analysis. Many such applications utilize binary representations of chemical structures...

Integration of Pharmaceutical Product Development in Asia/Japan Into the Global Program

Integration of Pharmaceutical Product Development in Asia/Japan Into the Global Program

Conference: DIA

With increasing global acceptance of the provisions in various guideline documents resulting from the International Conferences on Harmonization (ICH) and the advent of regulatory changes in Asia Pacific…

Results of a new classification algorithm combining K nearest neighbors and recursive partitioning

Results of a new classification algorithm combining K nearest neighbors and recursive partitioning

Authors: Miller DW
Publication: J Chem Inf Model
Software: MedChem Studio™

We present results of a new computational learning algorithm combining favorable elements of two well-known techniques:  K nearest neighbors and recursive partitioning.

Influence of Dose Size on Dose Response Relationships for Linezolid Efficacy Using Monte Carlo Simulations

Influence of Dose Size on Dose Response Relationships for Linezolid Efficacy Using Monte Carlo Simulations

Conference: AAPS

Phase II linezolid (LZD) data analyses suggested that AUC0-24/MIC ratio was an important predictor of efficacy outcome. Monte Carlo simulations were performed to determine whether dose size…

Time Course Distributions of Laboratory Indices: A Strategy for Evaluating Laboratory Data from Clinical Trials

Time Course Distributions of Laboratory Indices: A Strategy for Evaluating Laboratory Data from Clinical Trials

Conference: ICAAC

The traditional approach for assessing drug safety is to compute the baseline to end of treatment change in a laboratory measure. This strategy may miss important time-dependent value trends in patient...

Population Pharmacokinetics (PK) of Linezolid in Patients with Community-Acquired Pneumonia (CAP) and Skin and Soft Tissue (SST) Infections

Population Pharmacokinetics (PK) of Linezolid in Patients with Community-Acquired Pneumonia (CAP) and Skin and Soft Tissue (SST) Infections

Conference: ICAAC

A population PK analysis from 3 linezolid (LZD) trials was performed to estimate PK parameters in patients with CAP and SST infections, and evaluate patient covariate influence on LZD PK.

Characterization Of Oritavancin Pharmacokinetics (Pk) In Plasma And Blister Fluid In Normal Healthy Volunteers

Characterization Of Oritavancin Pharmacokinetics (Pk) In Plasma And Blister Fluid In Normal Healthy Volunteers

Conference: ICAAC

Oritavancin is a novel glycopeptide antibiotic currently being developed for the treatment of complicated skin/skin structure infections (cSSSI), including those caused by multi-drug resistant Gram-positive…

A strategy for Urinary Incotinence Management in the Nursing Home – A Mandated Outcome Measure

A strategy for Urinary Incotinence Management in the Nursing Home – A Mandated Outcome Measure

Conference: DIA

Urinary incontinence (UI) is prevalent in more than 50% of nursing home residents. It significantly affects the quality of a resident's life and is one of the most common complaints by family members.

Phase III Population Pharmacokinetics And Pharmacodynamics Of Azimilide

Phase III Population Pharmacokinetics And Pharmacodynamics Of Azimilide

Conference: AAPS

Azimilide (AZ) is a class III antiarrhythmic drug being developed for the treatment of symptomatic atrial fibrillation/flutter (AF/FL) and/or symptomatic paroxysmal supraventricular tachycardia…

The Development of a Population Pharmacokinetic (PK) Model for Linezolid

The Development of a Population Pharmacokinetic (PK) Model for Linezolid

Conference: ICAAC

Linezoid (lzd) is an oxazolidinone antibiotic under development for infection due to gram-positive bacteria. It is rapidly and extensively absorbed following oral administration and initial PK studies…

Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies

Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies

Publication: Eur J Drug Metab Pharmacokinet

Currently, the use of classical bioequivalence criteria is being called into question for certain classes of drugs such as bisphosphonates. These compounds typically possess a wide therapeutic index but may...

Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage

Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage

Publication: Pharm Res

Data collected during Phase I and II in the development of tirilazad were pooled and analyzed using nonlinear mixed effects models to assess covariates which might affect tirilazad pharmacokinetics.